1 Amendments of Barbara MATERA related to 2016/2096(INI)
Amendment 295 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Member States, when applying Regulation (EU) No 536/2014 in clinical trials of medicinal products for human use, to ensure equality in thuse a methodological approach for clinical trials that guarantees an adequate representation of men and women, in clinical trialsf applicable, paying special attention to transparency as regards the gender composition of participants, and – when considering the proper implementation of this regulation – to specifically monitor the level of representation of women and men;